IPI-3063

IPI-3063

Cat. No.: DIA-0230715

Size: 50 mg Size: 500 mg Size: Customer Size
Product Information
CAS No. 1425043-73-7
Formula C25H25N7O2
Molecular Weight 455.51
SMILES CC(C)N1C(=O)C2=C(C=CC=C2C=C1C(C)NC3=C(C#N)C(=NC=N3)N)C4=CN(C)C(=O)C=C4
Target p110δ
Product Description IPI-3063 is a potent and selective p110δ inhibitor with biochemical IC50 of 2.5 ± 1.2 nM and IC50 values for the other class I PI3K isoforms (p110α, p110β, p110γ) are at least 400-fold higher.
Format & Storage
Purity > 99%
Shipping Shipped on dry ice.
Storage Powder: -20 °C, 3 years; 4 °C, 2 years In solvent: -80 °C, 6 months; -20 °C, 1 month
Solubility Overview Soluble in DMSO
All of our services and products are intended for preclinical research use only and cannot be used to diagnose, treat or manage patients.
logo

Ace Therapeutics has a team of wellknown experts in the field of endocrine and metabolic research, aiming to provide innovative preclinical contract research solutions to cope with diabetes and its complications. We provide customized solutions and technical support, enabling the transformation of promising concepts into innovative treatments, thus accelerating the drug development process of diabetes.

Quick Links
Contact Info
Copyright © Ace Therapeutics. All Rights Reserved.
Top